The Recent Advances in the Management of Valvular Heart Disease Symposium is a one-day course specifically designed for practicing physicians and trainees involved in the care of patients with valvular heart disease, highlighting most recent advances in this field. It will specifically focus on evidence based information assisting in the multidisciplinary management of this patient group, as well as the description of newer diagnostic and therapeutic platforms. It will serve as a venue to discuss cases with a panel of experts in order to provide improvement in the competence performance, and patient care. The Symposium will provide a state-of-the-art learning opportunity for Physicians and Allied Health Professionals, who will have the opportunity to learn and interact with experts in their fields.
At the end of this CME activity participants should be able to:
· Define the role of medical therapy for the treatment of functional mitral regurgitation.
· Describe the use echocardiography and fluoroscopy fusion during complex valvular cases.
· Describe the use of transcatheter valve replacement for the treatment of aortic insufficiency.
· Describe the current trends and catheter technology aimed at treating tricuspid regurgitation.
· Identify the role of catheter based chordal replacement for the treatment of mitral regurgitation.
· Describe the current indications and limitations of tricuspid valve surgery.
· Describe the current scope of catheter based mitral valve replacement.
The 2018 Recent Advances in the Management of Valvular Heart Disease Symposium has been designed to meet the educational needs of Cardiologists, Cardiac Surgeons, Internists, Anesthesiologists, Radiologists, Fellows in Training, and Allied Health Professionals involved in the care of patients with valvular heart disease.